Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Circulation ; 148(23): 1870-1886, 2023 12 05.
Article in English | MEDLINE | ID: mdl-37886847

ABSTRACT

BACKGROUND: Microvasculature dysfunction is a common finding in pathologic remodeling of the heart and is thought to play an important role in the pathogenesis of hypertrophic cardiomyopathy (HCM), a disease caused by sarcomere gene mutations. We hypothesized that microvascular dysfunction in HCM was secondary to abnormal microvascular growth and could occur independent of ventricular hypertrophy. METHODS: We used multimodality imaging methods to track the temporality of microvascular dysfunction in HCM mouse models harboring mutations in the sarcomere genes Mybpc3 (cardiac myosin binding protein C3) or Myh6 (myosin heavy chain 6). We performed complementary molecular methods to assess protein quantity, interactions, and post-translational modifications to identify mechanisms regulating this response. We manipulated select molecular pathways in vivo using both genetic and pharmacological methods to validate these mechanisms. RESULTS: We found that microvascular dysfunction in our HCM models occurred secondary to reduced myocardial capillary growth during the early postnatal time period and could occur before the onset of myocardial hypertrophy. We discovered that the E3 ubiquitin protein ligase MDM2 (murine double minute 2) dynamically regulates the protein stability of both HIF1α (hypoxia-inducible factor 1 alpha) and HIF2α (hypoxia-inducible factor 2 alpha)/EPAS1 (endothelial PAS domain protein 1) through canonical and noncanonical mechanisms. The resulting HIF imbalance leads to reduced proangiogenic gene expression during a key period of myocardial capillary growth. Reducing MDM2 protein levels by genetic or pharmacological methods normalized HIF protein levels and prevented the development of microvascular dysfunction in both HCM models. CONCLUSIONS: Our results show that sarcomere mutations induce cardiomyocyte MDM2 signaling during the earliest stages of disease, and this leads to long-term changes in the myocardial microenvironment.


Subject(s)
Cardiomyopathy, Hypertrophic , Proto-Oncogene Proteins c-mdm2 , Mice , Animals , Proto-Oncogene Proteins c-mdm2/genetics , Proto-Oncogene Proteins c-mdm2/metabolism , Myocardium/metabolism , Myocytes, Cardiac/metabolism , Sarcomeres/metabolism , Mutation , Hypertrophy , Myosin Heavy Chains/genetics , Myosin Heavy Chains/metabolism
3.
Org Biomol Chem ; 17(21): 5230-5233, 2019 05 29.
Article in English | MEDLINE | ID: mdl-30990508

ABSTRACT

A p-nitrophenyl based rhodamine probe (NPRB) has been designed and synthesized for the selective, real-time detection of Al(iii) in aqueous medium with a lower micromolar range detection limit at physiological pH. All the spectroscopic and theoretical analyses validated the proposed 1 : 1 complexation between NPRB and Al3+ along with an 80-fold enhancement in fluorescence intensity. Using the "turn on" response of the probe, binding of NPRB to Al3+ in the brain tissue of adult male zebrafish (D. rerio) has been visualized through fluorescence microscopy.


Subject(s)
Aluminum/analysis , Brain/diagnostic imaging , Fluorescent Dyes/chemistry , Optical Imaging , Rhodamines/chemistry , Zebrafish , Animals , Ions/analysis , Male , Microscopy, Fluorescence
4.
Ecotoxicol Environ Saf ; 174: 574-583, 2019 Jun 15.
Article in English | MEDLINE | ID: mdl-30870658

ABSTRACT

Endocrine disruptors interfere with normal sexual and reproductive development of numerous organisms. Widely used in several chemical and manufacturing industries, nonylphenol (NP), a potent xenoestrogen, has the potential to perturb immune system. Using rat splenic macrophages (SMΦ) as the model system, NP-modulation of lipopolysaccharide (LPS)-induced inflammatory response has been investigated. Our results demonstrate that NP (0.1-10 µM) attenuates catalase activity, reactive oxygen species (ROS) generation and nitric oxide (NO) synthesis in LPS-treated SMΦ in vitro. NP inhibition of LPS-induced nuclear factor kappa B (NF-κB) activation and pro-inflammatory cytokine gene expression corroborate well with attenuation of suppressor of cytokine signalling 3 (SOCS3). Besides, elevated expression of anti-inflammatory factors reveals inverse correlation with suppression of endotoxin-induced M1 polarization in NP pre-incubated cells. While LPS promotes, NP prevents ERK1/2 (extracellular-signa1-regulated kinase 1/2) phosphorylation and MEK-inhibitor abrogates SOCS3 expression and NO production suggesting involvement of ERK1/2 in NP inhibition of SOCS3 expression. Further, translational inhibitor cycloheximide prevents LPS-induced NF-κB activation indicating functional importance of de novo synthesis of SOCS3, at least in part, in toll-like receptor 4 (TLR4)-mediated inflammatory response. Collectively, present study provides evidence favouring participation of SOCS3 in NP modulation of inflammatory response in rat SMΦ.


Subject(s)
Lipopolysaccharides/pharmacology , Macrophages/drug effects , Phenols/pharmacology , Suppressor of Cytokine Signaling 3 Protein/metabolism , Animals , Catalase/metabolism , Cytokines/genetics , Cytokines/metabolism , Drug Interactions , Extracellular Signal-Regulated MAP Kinases/metabolism , Macrophages/enzymology , Macrophages/metabolism , Male , NF-kappa B/metabolism , Nitric Oxide/metabolism , Rats , Reactive Oxygen Species/metabolism , Spleen/cytology , Toll-Like Receptor 4/metabolism
5.
Zygote ; 26(1): 62-75, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29229010

ABSTRACT

Participation and relative importance of phosphatidylinositol-3 kinase (PI3K) and mitogen-activated protein kinase (MAPK) signalling, either alone or in combination, have been investigated during 17α,20ß-dihydroxy-4-pregnen-3-one (DHP)-induced meiotic G2-M1 transition in denuded zebrafish oocyte. Results demonstrate that concomitant with rapid phosphorylation (activation) of Akt (Ser473) and MAPK (ERK1/2) at as early as 15 min of incubation, DHP stimulation promotes enhanced an GVBD response and histone H1 kinase activation between 1 and 5 h in full-grown oocytes in vitro. While p-Akt reaches its peak at 60 to 90 min and undergoes downregulation to the basal level by 240 min, ERK1/2 phosphorylation (activation) increases gradually until 120 min and remains high thereafter. Although, priming with MEK1/2 inhibitor U0126 is without effect, PI3K inhibitors, wortmannin or LY294002, delay the GVBD response significantly (P < 0.001) until 3 h but not at 5 h of incubation. Interestingly, blocking PI3K and MEK function together could abrogate steroid-induced oocyte maturation at all time points tested. While DHP stimulation promotes phospho-PKA catalytic (p-PKAc) dephosphorylation (inactivation) between 30-120 min of incubation, simultaneous inhibition of PI3K and MEK1/2 kinases abrogates DHP action. Conversely, elevated intra-oocyte cAMP, through priming with either adenylyl cyclase (AC) activator forskolin (FK) or dibutyryl cAMP (db-cAMP), abrogates steroid-induced Akt and ERK1/2 phosphorylation. Taken together, these results suggest that DHP-induced Akt and ERK activation precedes the onset of meiosis (GVBD response) in a cAMP-sensitive manner and PI3K/Akt and MEK/MAPK pathways together have a pivotal influence in the downregulation of PKA and resumption of meiotic maturation in zebrafish oocytes in vitro.


Subject(s)
Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Oocytes/physiology , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Animals , Cyclic AMP/metabolism , Enzyme Inhibitors/pharmacology , Female , G2 Phase/physiology , In Vitro Oocyte Maturation Techniques , MAP Kinase Kinase 1/metabolism , Meiosis/physiology , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3/antagonists & inhibitors , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Pregnenes/pharmacology , Signal Transduction/drug effects , Zebrafish , Zebrafish Proteins/metabolism
6.
Reproduction ; 151(1): 59-72, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26500283

ABSTRACT

Binding of 17ß-estradiol (E2) to novel G-protein coupled receptor, Gper1, promotes intra-oocyte adenylyl cyclase activity and transactivates epidermal growth factor receptor to ensure prophase-I arrest. Although involvement of either membrane progestin receptor (mPR) or Igf system has been implicated in regulation of meiosis resumption, possibility of concurrent activation and potential synergism between 17α,20ß-dihydroxy-4-pregnen-3-one (DHP)- and Igf-mediated signalling cascades in alleviating E2 inhibition of oocyte maturation (OM) has not been investigated. Here using zebrafish (Danio rerio) defolliculated oocytes, we examined the effect of DHP and Igf1, either alone or in combination, in presence or absence of E2, on OM in vitro. While priming of denuded oocytes with E2 blocked spontaneous maturation, co-treatment with DHP (3 nM) and Igf1 (10 nM), but not alone, reversed E2 inhibition and promoted a robust increase in germinal vesicle breakdown (GVBD). Although stimulation with either Igf1 or DHP promoted Akt phosphorylation, pharmacological inhibition of PI3K/Akt signalling prevented Igf1-induced GVBD but delayed DHP action till 4-5 h of incubation. Moreover, high intra-oocyte cAMP attenuates both DHP and Igf1-mediated OM and co-stimulation with DHP and Igf1 could effectively reverse E2 action on PKA phosphorylation. Interestingly, data from in vivo studies reveal that heightened expression of igf1, igf3 transcripts in intact follicles corresponded well with elevated phosphorylation of Igf1r and Akt, mPRa immunoreactivity, PKA inhibition and accelerated GVBD response just prior to ovulation. This indicates potential synergism between maturational steroid and Igf1 which might have physiological relevance in overcoming E2 inhibition of meiosis resumption in zebrafish oocytes.


Subject(s)
Hydroxyprogesterones/pharmacology , Oocytes/cytology , Prophase/physiology , Somatomedins/pharmacology , Zebrafish Proteins/pharmacology , Zebrafish , Animals , Cyclic AMP/physiology , Cyclic AMP-Dependent Protein Kinases/metabolism , Drug Synergism , Estradiol/pharmacology , Female , Oocytes/drug effects , Oocytes/growth & development , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation/drug effects , Prophase/drug effects , Signal Transduction/drug effects , Somatomedins/physiology , Zebrafish Proteins/physiology
7.
Gen Comp Endocrinol ; 239: 21-31, 2016 12 01.
Article in English | MEDLINE | ID: mdl-26853486

ABSTRACT

Present study reports differential expression of the two insulin receptor (IR) subtypes in zebrafish ovary at various stages of follicular growth and potential involvement of IR in insulin-induced oocyte maturation. The results showed that mRNA expression for IR subtypes, insra and insrb, exhibited higher levels in mid-vitellogenic (MV) and full-grown (FG) rather than pre-vitellogenic (PV) oocytes. Interestingly, compared to the levels in denuded oocytes, mRNAs for both insra and insrb were expressed at much higher level in the follicle layer harvested from FG oocytes. Immunoprecipitation using IRß antibody could detect a protein band of desired size (∼95kDa) in FG oocyte lysates. Further, IRß immunoreactivity was detected in ovarian tissue sections, especially at the follicle layer and oocyte membrane of MV and FG, but not PV stage oocytes. While hCG (10IU/ml) stimulation was without effect, priming with insulin (5µM) could promote oocyte maturation of MV oocytes in a manner sensitive to de novo protein and steroid biosynthesis. Compared to hCG, in insulin pre-incubated MV oocytes, stimulation with maturation inducing steroid (MIS), 17α,20ß-dihydroxy-4-pregnen-3-one (DHP) elicited higher maturational response. Potential involvement of insulin-mediated action on acquisition of maturational competence and regulation of oocyte maturation was further manifested through up regulation of 20ß-hydroxysteroid dehydrogenase (20ß-hsd), MIS receptor (mPRα), insulin-like growth factor 3 (igf3) and IGF1 receptor (igf1rb), but not cyp19a expression in MV oocytes. Moreover, priming with anti-IRß attenuated insulin action on meiotic G2-M1 transition indicating the specificity of insulin action and physiological relevance of IR in zebrafish ovary.


Subject(s)
Insulin/pharmacology , Oogenesis/drug effects , Ovary/drug effects , Ovary/metabolism , Receptor, Insulin/genetics , Zebrafish/genetics , Animals , Female , Insulin/metabolism , Oocytes/drug effects , Oocytes/metabolism , Oogenesis/genetics , Ovarian Follicle/drug effects , Ovarian Follicle/metabolism , Ovary/physiology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Receptor, Insulin/metabolism , Receptors, Steroid/genetics , Receptors, Steroid/metabolism , Somatomedins/metabolism , Zebrafish/physiology , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
8.
Zygote ; 24(2): 181-94, 2016 Apr.
Article in English | MEDLINE | ID: mdl-25707854

ABSTRACT

Regulation of insulin-mediated resumption of meiotic maturation in catfish oocytes was investigated. Insulin stimulation of post-vitellogenic oocytes promotes the synthesis of cyclin B, histone H1 kinase activation and a germinal vesicle breakdown (GVBD) response in a dose-dependent and duration-dependent manner. The PI3K inhibitor wortmannin abrogates recombinant human (rh)-insulin action on histone H1 kinase activation and meiotic G2-M1 transition in denuded and follicle-enclosed oocytes in vitro. While the translational inhibitor cycloheximide attenuates rh-insulin action, priming with transcriptional blocker actinomycin D prevents insulin-stimulated maturational response appreciably, albeit in low amounts. Compared with rh-insulin, human chorionic gonadotrophin (hCG) stimulation of follicle-enclosed oocytes in vitro triggers a sharp increase in 17α,20ß-dihydroxy-4-pregnen-3-one (17α,20ß-DHP) secreted in the incubation medium at 12 h. Interestingly, the insulin, but not the hCG-induced, maturational response shows less susceptibility to steroidogenesis inhibitors, trilostane or dl-aminoglutethimide. In addition, priming with phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX) or cell-permeable dbcAMP or adenylyl cyclase activator forskolin reverses the action of insulin on meiotic G2-M1 transition. Conversely, the adenylyl cyclase inhibitor, SQ 22536, or PKA inhibitor H89 promotes the resumption of meiosis alone and further potentiates the GVBD response in the presence of rh-insulin. Furthermore, insulin-mediated meiotic maturation involves the down-regulation of endogenous protein kinase A (PKA) activity in a manner sensitive to PI3K activation, suggesting potential involvement of a cross-talk between cAMP/PKA and insulin-mediated signalling cascade in catfish oocytes in vitro. Taken together, these results suggest that rh-insulin regulation of the maturational response in C. batrachus oocytes involves down-regulation of PKA, synthesis of cyclin B, and histone H1 kinase activation and demonstrates reduced sensitivity to steroidogenesis and transcriptional inhibition.


Subject(s)
Cell Cycle/drug effects , Insulin/pharmacology , Meiosis/drug effects , Oocytes/drug effects , Animals , Catfishes , Cells, Cultured , Chorionic Gonadotropin/pharmacology , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclin B/metabolism , Cycloheximide/pharmacology , Dactinomycin/pharmacology , Dose-Response Relationship, Drug , Female , Hydroxyprogesterones/metabolism , Immunoblotting , Insulin/genetics , Oocytes/cytology , Oocytes/physiology , Ovarian Follicle/cytology , Protein Kinases/metabolism , Protein Synthesis Inhibitors/pharmacology , Recombinant Proteins/pharmacology , Time Factors
9.
Cardiovasc Res ; 118(9): 2124-2138, 2022 07 20.
Article in English | MEDLINE | ID: mdl-34329394

ABSTRACT

AIMS: The cardiac natriuretic peptides [atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP)] are important regulators of cardiovascular physiology, with reduced natriuretic peptide (NP) activity linked to multiple human cardiovascular diseases. We hypothesized that deficiency of either ANP or BNP would lead to similar changes in left ventricular structure and function given their shared receptor affinities. METHODS AND RESULTS: We directly compared murine models deficient of ANP or BNP in the same genetic backgrounds (C57BL6/J) and environments. We evaluated control, ANP-deficient (Nppa-/-) or BNP-deficient (Nppb-/-) mice under unstressed conditions and multiple forms of pathological myocardial stress. Survival, myocardial structure, function and electrophysiology, tissue histology, and biochemical analyses were evaluated in the groups. In vitro validation of our findings was performed using human-derived induced pluripotent stem cell cardiomyocytes (iPS-CMs). In the unstressed state, both ANP- and BNP-deficient mice displayed mild ventricular hypertrophy which did not increase up to 1 year of life. NP-deficient mice exposed to acute myocardial stress secondary to thoracic aortic constriction (TAC) had similar pathological myocardial remodelling but a significant increase in sudden death. We discovered that the NP-deficient mice are more susceptible to stress-induced ventricular arrhythmias using both in vivo and ex vivo models. Mechanistically, deficiency of either ANP or BNP led to reduced myocardial cGMP levels and reduced phosphorylation of the cAMP response element-binding protein (CREBS133) transcriptional regulator. Selective CREB inhibition sensitized wild-type hearts to stress-induced ventricular arrhythmias. ANP and BNP regulate cardiomyocyte CREBS133 phosphorylation through a cGMP-dependent protein kinase 1 (PKG1) and p38 mitogen-activated protein kinase (p38 MAPK) signalling cascade. CONCLUSIONS: Our data show that ANP and BNP act in a non-redundant fashion to maintain myocardial cGMP levels to regulate cardiomyocyte p38 MAPK and CREB activity. Cardiac natriuretic peptide deficiency leads to a reduction in CREB signalling which sensitizes the heart to stress-induced ventricular arrhythmias.


Subject(s)
Arrhythmias, Cardiac , Atrial Natriuretic Factor , Natriuretic Peptide, Brain , Animals , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/metabolism , Atrial Natriuretic Factor/genetics , Atrial Natriuretic Factor/metabolism , Cyclic GMP , Mice , Myocytes, Cardiac/metabolism , Natriuretic Peptide, Brain/genetics , Natriuretic Peptide, Brain/metabolism , Natriuretic Peptides/metabolism , Vasodilator Agents , p38 Mitogen-Activated Protein Kinases
10.
J Am Heart Assoc ; 10(15): e021768, 2021 08 03.
Article in English | MEDLINE | ID: mdl-34323119

ABSTRACT

Background Sarcomere gene mutations lead to cardiomyocyte hypertrophy and pathological myocardial remodeling. However, there is considerable phenotypic heterogeneity at both the cellular and the organ level, suggesting modifiers regulate the effects of these mutations. We hypothesized that sarcomere dysfunction leads to cardiomyocyte genotoxic stress, and this modifies pathological ventricular remodeling. Methods and Results Using a murine model deficient in the sarcomere protein, Mybpc3-/- (cardiac myosin-binding protein 3), we discovered that there was a surge in cardiomyocyte nuclear DNA damage during the earliest stages of cardiomyopathy. This was accompanied by a selective increase in ataxia telangiectasia and rad3-related phosphorylation and increased p53 protein accumulation. The cause of the DNA damage and DNA damage pathway activation was dysregulated cardiomyocyte DNA synthesis, leading to replication stress. We discovered that selective inhibition of ataxia telangiectasia and rad3 related or cardiomyocyte deletion of p53 reduced pathological left ventricular remodeling and cardiomyocyte hypertrophy in Mybpc3-/- animals. Mice and humans harboring other types of sarcomere gene mutations also had evidence of activation of the replication stress response, and this was associated with cardiomyocyte aneuploidy in all models studied. Conclusions Collectively, our results show that sarcomere mutations lead to activation of the cardiomyocyte replication stress response, which modifies pathological myocardial remodeling in sarcomeric cardiomyopathy.


Subject(s)
Cardiac Myosins/genetics , Cardiomyopathies , Carrier Proteins , DNA Damage , Myocytes, Cardiac/metabolism , Sarcomeres , Ventricular Remodeling/genetics , Animals , Ataxia Telangiectasia Mutated Proteins/metabolism , Cardiomyopathies/genetics , Cardiomyopathies/pathology , Carrier Proteins/genetics , Carrier Proteins/metabolism , Disease Models, Animal , Mice , Mice, Knockout , Mutation , Sarcomeres/genetics , Sarcomeres/metabolism
11.
Mol Cell Endocrinol ; 496: 110544, 2019 10 01.
Article in English | MEDLINE | ID: mdl-31419465

ABSTRACT

Participation of cyclic nucleotide-mediated signaling in nitric oxide/soluble guanylate cyclase (NO/sGC) regulation of oocyte maturation (OM) in perch (Anabas testudineus) follicle-enclosed oocytes has been investigated. Congruent with sharp decline in follicular cyclic GMP (cGMP) level, nitric oxide synthase (NOS)-inhibitor (L-NAME) attenuates protein kinase A (PKA) phosphorylation but promotes p-ERK1/2 and p-p34Cdc2 (Thr-161) in maturing oocytes. Conversely, NO donor (SNP) prevents OM, potentially through elevated cGMP synthesis. Expression and localization of Nos2 and Nos3 immunoreactivity in perch ovary varied considerably at progressively higher stages of folliculogenesis. While sGC inhibitor (ODQ) alone could induce OM, 8-bromo-cGMP attenuates 17,20ß-P-induced OM indicating functional significance of NO/sGC/cGMP in perch ovary. Interestingly, high NO/cGMP inhibition of OM shows positive relation with elevated cAMP level. MIS induced OM is more susceptible to the oocyte-specific phosphodiesterase (PDE) 3 than PDE4 inhibition. Collectively, high NO/cGMP attenuation of OM potentially involves PDE3 inhibition, cAMP accumulation and PKA activation.


Subject(s)
Cyclic GMP/metabolism , Fish Proteins/biosynthesis , Fishes/metabolism , Gene Expression Regulation, Enzymologic , Meiosis , Nitric Oxide Synthase Type III/biosynthesis , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide/metabolism , Ovary/enzymology , Animals , Female
12.
Mol Cell Endocrinol ; 460: 162-169, 2018 01 15.
Article in English | MEDLINE | ID: mdl-28743518

ABSTRACT

Nitric oxide (NO) regulation of ovarian function in mammals has been studied extensively. However, relatively less information is available on NO action on meiotic G2-M1 transition in teleost oocytes. In the present study using follicle-enclosed oocytes of Anabas testudineus, NO regulation of intra-oocyte signaling events during meiotic G2-M1 transition were examined. Priming with NO donor, sodium nitroprusside (SNP) prevented 17α,20ß-dihydroxy-4-pregenen-3-one (17,20ß-P)-induced germinal vesicle break down (GVBD) in dose- and duration-dependent manner. Impaired GVBD response in SNP-treated groups corroborated well with reduced p34Cdc2 (Thr161) phosphorylation. Immunoblot analysis revealed that congruent with elevated cAMP-dependent protein kinase (PKA) phosphorylation (activation), NO inhibition of meiotic maturation involves down regulation of Cdc25 activation, Mos synthesis and MAPK3/1 (ERK1/2) phosphorylation. However, priming with PKA inhibitor (H89) could reverse SNP attenuation of oocyte GVBD significantly. Collectively our results indicate that negative influence of NO on meiotic G2-M1 transition in perch oocytes might involve PKA activation.


Subject(s)
Cell Division/drug effects , Cyclic AMP-Dependent Protein Kinases/metabolism , Fishes/metabolism , G2 Phase/drug effects , Meiosis/drug effects , Nitric Oxide/pharmacology , Oocytes/cytology , Signal Transduction , Animals , CDC2 Protein Kinase/metabolism , Enzyme Activation/drug effects , Female , Hydroxyprogesterones/pharmacology , MAP Kinase Signaling System/drug effects , Models, Biological , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , Oocytes/drug effects , Oocytes/metabolism , Phosphorylation , Signal Transduction/drug effects
13.
Mol Cell Endocrinol ; 476: 57-69, 2018 11 15.
Article in English | MEDLINE | ID: mdl-29715496

ABSTRACT

The effect of insulin priming on Il-10 expression, regulation of inflammatory cytokines and participation of intra-cellular signalling events, primarily ERK1/2 and PI3K/Akt, has been investigated in high glucose (HG) and/or lipopolysaccharide (LPS)-induced murine macrophages. Our results demonstrate that congruent with sharp increase in ERK1/2 and CREB phosphorylation, insulin stimulation in vitro promotes significant increase in Il-10 expression in mouse peritoneal macrophage and RAW 264.7 cells, both positive for anti-IRß. Pharmacological inhibition of MEK/MAPK, but not PI3K/Akt cascade, abrogates CREB phosphorylation and Il-10 synthesis indicating functional relevance of insulin action. Conversely, priming with PI3K inhibitor wortmannin prevents insulin attenuation of HG- and/or LPS-induced p38 MAPK and NF-κB activation, Tnf-α, Il-1ß expression as well as NO production. Congruent with reduced Il-10 expression, MEK inhibition abrogates insulin action allowing significant increase in Tlr4 expression and LPS response indicating insulin-induced Il-10 might have pivotal influence in regulation of chronic as well as acute inflammatory response.


Subject(s)
Insulin/metabolism , Lipopolysaccharides/pharmacology , Macrophages, Peritoneal/metabolism , Signal Transduction , Animals , Anti-Inflammatory Agents/metabolism , Cyclic AMP Response Element-Binding Protein/metabolism , Cytokines/genetics , Cytokines/metabolism , Gene Expression Regulation/drug effects , Glucose/toxicity , Inflammation/pathology , Inflammation Mediators/metabolism , Insulin/pharmacology , Macrophages, Peritoneal/drug effects , Male , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , RAW 264.7 Cells , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, Insulin/genetics , Receptor, Insulin/metabolism , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL